Valganciclovir to Prevent Cytomegalovirus Infection in Kidney and Kidney/Pancreas Transplant Recipients

NCT00034385 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

12

Enrollment

NIH

Sponsor class

Conditions

Kidney Trasplant

Interventions

DRUG: Valganciclovir

Sponsor

National Institutes of Health Clinical Center (CC)